Stay updated on Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial

Sign up to get notified when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    No meaningful changes detected in the Study Details page between the two screenshots; core information remains the same.
    Difference
    0.3%
    Check dated 2025-11-03T01:11:31.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    3%
    Check dated 2025-10-05T09:52:03.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new version is available.
    Difference
    0.1%
    Check dated 2025-09-28T03:11:25.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The revision updates from v3.0.1 to v3.0.2 and the Back to Top link has been removed. Overall, this is a small version update with a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-13T17:17:38.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T14:43:58.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page has undergone significant changes in its location details, with the addition of specific facility names and locations, while also removing previous location-related information and medical topics.
    Difference
    5%
    Check dated 2025-08-30T11:24:16.000Z thumbnail image

Stay in the know with updates to Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.